For example, by binding to its receptors, β-klotho (KLB) and FGF receptor 1 (FGFR1), FGF21 down-regulates hepatic sterol regulatory element binding protein-2 to inhibit cholesterol biosynthesis and induce adiponectin to inhibit atherosclerosis [28]. The gene discussed is KLB; the disease is atherosclerosis.